share_log

和黃醫藥:截至2024年9月30日止月份之股份發行人的證券變動月報表

HUTCHMED: Monthly Return of Equity Issuer on Movements in Securities for the month ended September 30, 2024

HKEX ·  Oct 2 16:31

Summary by Futu AI

和黃醫藥(中國)有限公司於2024年10月2日向香港交易及結算所有限公司提交了最新的證券變動月報表,涵蓋截至2024年9月30日的情況。報告顯示,公司的法定/註冊股本及已發行股份(不包括庫存股份)在該月份均無變動,維持在1,500,000,000美元及871,469,720股。此外,公司於2015年4月24日採納的股份期權計劃在本月內亦無變動,結存的股份期權數目為29,909,758。報告中未涉及香港預託證券的資料,且無其他股份或庫存股份的變動。報告由非執行董事兼公司秘書施熙德呈交。
和黃醫藥(中國)有限公司於2024年10月2日向香港交易及結算所有限公司提交了最新的證券變動月報表,涵蓋截至2024年9月30日的情況。報告顯示,公司的法定/註冊股本及已發行股份(不包括庫存股份)在該月份均無變動,維持在1,500,000,000美元及871,469,720股。此外,公司於2015年4月24日採納的股份期權計劃在本月內亦無變動,結存的股份期權數目為29,909,758。報告中未涉及香港預託證券的資料,且無其他股份或庫存股份的變動。報告由非執行董事兼公司秘書施熙德呈交。
In October 2, 2024, hutchmed (china) Limited submitted the latest monthly securities information report to the Hong Kong Stock Exchange and Clearing Limited, covering the situation up to September 30, 2024. The report shows that the company's authorized/registered share capital and issued shares (excluding treasury shares) remained unchanged at 1,500,000,000 US dollars and 871,469,720 shares for that month. In addition, the share options plan adopted by the company on April 24, 2015 also remained unchanged this month, with a remaining number of 29,909,758 share options. The report does not involve data on Hong Kong depositary securities and there are no other changes in shares or treasury shares. The report was submitted by non-executive director and company secretary Daniel Shek.
In October 2, 2024, hutchmed (china) Limited submitted the latest monthly securities information report to the Hong Kong Stock Exchange and Clearing Limited, covering the situation up to September 30, 2024. The report shows that the company's authorized/registered share capital and issued shares (excluding treasury shares) remained unchanged at 1,500,000,000 US dollars and 871,469,720 shares for that month. In addition, the share options plan adopted by the company on April 24, 2015 also remained unchanged this month, with a remaining number of 29,909,758 share options. The report does not involve data on Hong Kong depositary securities and there are no other changes in shares or treasury shares. The report was submitted by non-executive director and company secretary Daniel Shek.

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.